Watch SGHT. Know when insiders buy.
One email the day a filing lands. Free.
SGHT
Sight Sciences, Inc.
8.93
+0.25 +2.88%
USD · close Sep 25
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
0
FLAG · shorts 0
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $491.9MP/E —DIV YIELD —FCF YIELD -4.74%REV TTM $83.4M +9.3%NET INCOME −$29.8MNET CASH $37.4M52W 3.20 – 9.05SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $23.4M | +19.5% | 91.4% | −$3.9M | −$4.4M | — | -0.08 | −$5.7M | $19K | −$5.7M | Aug 5 |
| Q1 2026 · Mar 31 | $19.7M | +12.5% | 86.2% | −$12.4M | −$13M | — | -0.24 | −$7M | $60K | −$7.1M | May 6 |
| Q4 2025 · Dec 31derived | $20.4M | +6.9% | 87.3% | −$3.7M | −$4.2M | — | -0.08 | −$1.8M | −$156K | −$1.7M | Mar 4 |
| Q3 2025 · Sep 30 | $19.9M | −1.2% | 86.4% | −$7.9M | −$8.2M | — | -0.16 | −$8.7M | $170K | −$8.9M | Nov 6 |
| Q2 2025 · Jun 30 | $19.6M | −8.5% | 84.8% | −$11.7M | −$11.9M | — | -0.23 | −$7.5M | $210K | −$7.8M | Aug 5 |
| Q1 2025 · Mar 31 | $17.5M | −9.1% | 86.2% | −$13.9M | −$14.2M | — | -0.28 | −$11.6M | $0 | −$11.6M | May 6 |
| Q4 2024 · Dec 31derived | $19.1M | +1.7% | 86.8% | −$11.9M | −$11.8M | — | -0.24 | −$3.5M | $137K | −$3.6M | Mar 4 |
| Q3 2024 · Sep 30 | $20.2M | +0.7% | 83.9% | −$11.2M | −$11.1M | — | -0.22 | $362K | $51K | $311K | Nov 6 |
| Q2 2024 · Jun 30 | $21.4M | — | 85.8% | −$12.7M | −$12.3M | — | -0.25 | −$9.5M | $80K | −$9.5M | Aug 7 |
| Q1 2024 · Mar 31 | $19.3M | — | 85.5% | −$14.7M | −$16.3M | — | -0.33 | −$9.8M | $117K | −$9.9M | May 8 |
| Q4 2023 · Dec 31derived | $18.8M | — | 85.2% | −$11.1M | −$10.7M | — | -0.22 | −$6.5M | $264K | −$6.7M | Mar 7 |
| Q3 2023 · Sep 30 | $20M | — | 86.6% | −$13.4M | −$13M | — | -0.27 | −$9.8M | $304K | −$10.1M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $77.4M | 86.2% | −$37.1M | −$38.4M | -49.7% | -0.74 | −$29.7M | $224K | −$29.9M | — | — |
| FY2024 · to Dec 31 | $79.9M | 85.5% | −$50.5M | −$51.5M | -64.5% | -1.03 | −$22.4M | $385K | −$22.7M | — | — |
| FY2023 · to Dec 31 | $81.1M | 85.3% | −$57.3M | −$55.5M | -68.5% | -1.14 | −$47.2M | $791K | −$48M | — | — |
| FY2022 · to Dec 31 | $71.3M | 82.7% | −$84M | −$86.2M | -120.9% | -1.80 | −$76M | $970K | −$76.9M | — | — |
| FY2021 · to Dec 31 | $49M | 82.4% | −$51.5M | −$63M | -128.6% | -2.36 | −$52.5M | $813K | −$53.4M | — | — |
| FY2020 · to Dec 31 | $27.6M | 66.7% | −$32.2M | −$34.7M | -125.5% | -3.71 | −$32.2M | $953K | −$33.1M | — | — |
Every number comes from Sight Sciences, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.